Home Blog Page 917

CNN ORIGINAL SERIES “K-EVERYTHING” WITH DANIEL DAE KIM PREMIERES SATURDAY, MAY 9 ON CNN INTERNATIONAL

Trailer: https://youtu.be/tejmMouplGQ

HONG KONG, March 27, 2026 /PRNewswire/ — CNN Original Series K-Everything hosted, and executive produced by Tony-award nominated actor, director, producer, and social advocate Daniel Dae Kim will premiere on May 9 on CNN International. A cultural exploration of Korea’s explosive global influence, the series will air four episodes during the month of May.

CNN ORIGINAL SERIES “K-EVERYTHING” WITH DANIEL DAE KIM PREMIERES SATURDAY, MAY 9 ON CNN INTERNATIONAL
CNN ORIGINAL SERIES “K-EVERYTHING” WITH DANIEL DAE KIM PREMIERES SATURDAY, MAY 9 ON CNN INTERNATIONAL

“It’s both a personal and professional thrill to be able to showcase Korea through our series, K-Everything,” said Daniel Dae Kim. “There’s never been more interest in its people and culture, so it feels like the perfect time to explore the dynamics of its success. Whether you’re already a K-expert, or a newbie, we hope you’ll be able to gain a unique and fresh perspective on a place that means so much to me.”  

Across four immersive episodes, Kim explores the forces behind Korea’s cultural rise, tracing how distinct traditions evolved into global phenomena. In Seoul, the beating heart of the K-pop industry, he meets with some of the biggest stars in the business to reveal how Korean pop harnessed the devotion of worldwide superfans to dominate the charts. From K-drama film sets to cutting-edge special effects studios, he examines the dramatic ascent of K-film, from an era of strict censorship to Oscar triumphs and record- shattering streaming success for K-dramas. Kim attends a vibrant kimchi festival in Pyeongchang. He discovers how K-food is reshaping dining across the globe, from street food to three Michelin-starred restaurants. Finally, in photo studios, factories and beauty clinics, he unpacks the innovation and influence behind K-beauty, and how South Korea became the cosmetics capital of the world.  

“The global rise of Korean culture is one of the most exciting stories of our time and a powerful example of Korean soft power” said Ellana Lee, Group Senior Vice President, GM APAC, and Global Head of Productions for CNN International. “Through Daniel Dae Kim’s perspective, K-Everything brings CNN International audiences inside the creativity and innovation driving Korea’s influence across music, film, food and beauty, and why it continues to captivate people around the world.”  

Executive Producers for K-Everything are Daniel Dae Kim, along with Amy Entelis, Ellana Lee, Jon Jensen, Katie Hinman and Ryan Smith for CNN Original Series. K-Everything is the first collaboration between the network’s CNN Originals and APAC-based Global Productions teams.  

Additionally, a dedicated digital hub featuring a rich suite of digital and social content celebrating Korean creativity and cultural impact can be found at https://edition.cnn.com/world/k-everything.   

K-Everything continues the legacy of CNN Original Series’ host-led storytelling that examines global culture and the human experience, joining an award-winning library of premium programming streaming on the CNN app.  

The CNN Original Series is sponsored by one of South Korea’s largest companies, Hyundai Motor Company, a global brand deeply rooted in Korean heritage whose growth has mirrored the country’s own journey of innovation and progress.  

K-Everything premieres Saturday, May 9 at 8pm HKT and replays at 8am HKT on Sunday, May 10 and 3am HKT on Monday, May 11 on CNN International.

About CNN Originals
The CNN Originals group develops, produces and acquires original, long-form unscripted programming for CNN Worldwide. Amy Entelis, executive vice president of talent, CNN Originals and creative development, oversees the award-winning CNN Originals portfolio that includes the following premium content brands: CNN Original Series, CNN Films, CNN Presents, and the newly formed CNN Studios, an internal production studio which creates long-form programming for CNN’s global platforms. Since 2012, the team has overseen and executive produced more than 45 multi-part documentary series and 60 feature-length documentary films, earning more than 110 awards and 445 nominations for the cable network, including CNN Films’ first Academy Award® for Navalny. Acclaimed titles include the Peabody Award winning and 13-time Emmy® Award-winning Anthony Bourdain Parts Unknown; five time Emmy® nominee, Apollo 11, directed by Todd Douglas Miller; Emmy® nominated Eva Longoria: Searching for Mexico; the Emmy® Award-nominated “Decades Series”: The Sixties, The Seventies, The Eighties, The Nineties, The 2000s, and The 2010s, executive produced by Tom Hanks and Gary Goetzman; The Last Movie Stars, directed by Ethan Hawke about the lives and careers of actors and humanitarians Joanne Woodward and Paul Newman; Grammy® Award nominee Little Richard: I Am Everything, directed by Lisa Cortés; The Many Lives of Martha Stewart; This is Life with Lisa Ling; Primetime Emmy® and duPont-Columbia Award-winning, RBG, directed by Betsy West and Julie Cohen; See It Loud: The History of Black Television, executive produced by LeBron James and Maverick Carter; Space Shuttle Columbia: The Final Flight in partnership with the BBC; the Producers Guild Award and three-time Emmy® Award-winning Stanley Tucci: Searching for Italy; BAFTA nominee and Directors Guild Award winner, Three Identical Strangers, directed by Tim Wardle; and the five-time Emmy® Award-winning United Shades of America with W. Kamau Bell; and the five-time Emmy® Award-winning The Whole Story with Anderson Cooper. CNN Originals can be seen on CNN, to stream via a CNN All Access subscription, on the CNN Original Hub on HBO Max and discovery+, on the CNN Originals FAST channel, and with a pay TV subscription via CNN.com, CNN apps and cable operator platforms. 

About CNN International  
CNN’s portfolio of news and information services is available in seven different languages across all major TV, digital and mobile platforms, reaching more than 379 million households around the globe. CNN International is the number one international TV news channel according to all major media surveys across Europe, the Middle East and Africa, the Asia Pacific region, and Latin America and has a US presence that includes CNNgo. CNN Digital is a leading network for online news, mobile news and social media. CNN is at the forefront of digital innovation and continues to invest heavily in expanding its digital global footprint, with a suite of award-winning digital properties and a range of strategic content partnerships, commercialised through a strong data-driven understanding of audience behaviours. CNN has won multiple prestigious awards around the world for its journalism. Around 1,000 hours of long-form series, documentaries and specials are produced every year by CNNI’s non-news programming division. CNN has 36 editorial offices and more than 1,100 affiliates worldwide through CNN Newsource. CNN International is a Warner Bros. Discovery company.

2,400 sqm: Asia’s Largest Indoor Transparent Screen Shines at Central World, Thailand

BANGKOK, March 27, 2026 /PRNewswire/ — Recently, the largest indoor transparent screen project in Asia, built by global LED leader Unilumin, was officially completed at Central World in Bangkok, Thailand. Covering a total area of 2,400 square meters, this landmark project sets a new benchmark for the digital transformation of commercial complexes across Southeast Asia and the entire Asian region.

Asia's Largest Indoor Transparent Screen at Central World by Unilumin
Asia’s Largest Indoor Transparent Screen at Central World by Unilumin

The project employs Unilumin’s UVF series transparent screen (10 mm pixel pitch), which delivers a brightness of 8,000 cd/㎡, a transparency rate exceeding 70%, and a lightweight design of only 8 kg/㎡. With a 7680Hz high refresh rate and 16-bit grayscale processing, the display produces delicate, smooth images and authentic, natural colors—even under intense ambient light.

To adapt to the complex architectural structure, the Unilumin team developed multiple structural installation solutions, including frame curtain walls, point-supported curtain walls, and hoisting methods, fully demonstrating the product’s flexibility and adaptability. The screen also supports a customized front-black, back-white aesthetic that seamlessly integrates with the building’s design.

The project, initiated in 2023, involved three years of sampling, testing, and optimization. From design to surveys, the Unilumin team maintained close communication with the client, earning trust through exceptional display quality, stable performance, and efficient heat dissipation. During delivery, R&D and production teams swiftly responded to changing requirements, completing upgrades and batch deliveries, while technical staff provided on-site support.

Adjacent to the Erawan Shrine—the site sees an average daily foot traffic of over 400,000 people. As a key visual centerpiece in the shopping district, this transparent screen not only enhances the complex’s technological appeal and commercial atmosphere but has also become a popular Instagram spot for tourists. Whether for brand exposure, content display, or public art presentation, the project demonstrates immense commercial value and social influence.

About Unilumin

Unilumin is a global leader in LED displays, lighting products, and integrated Metasight solutions, ranked among the Top 500 Asian Brands for 3 consecutive years, operating in 160+ countries with R&D centers in China, Japan, and the U.S., and the world’s largest intelligent LED manufacturing base. Unilumin has completed a series of milestone projects, such as the world’s largest holographic screen at Spring Cocoon, the 22,000-square-meter Riyadh Season and Boulevard World immersive mega projects in Saudi Arabia, and the world’s first acoustically transparent LED cinema screen.

For more information, please visit https://www.unilumin.com

VOYAGE Vietnam: A quiet culinary journey shaping the future of fine dining in Asia

HO CHI MINH CITY, Vietnam, March 27, 2026 /PRNewswire/ — There are restaurants that dazzle, and those that linger. VOYAGE belongs firmly to the latter. Set within the restless energy of Ho Chi Minh City, this intimate dining destination offers an experience defined not by spectacle, but by stillness — a rare, deliberate pause in the rhythm of contemporary gastronomy.

VOYAGE is located at 51 Lê Văn Miến Street, An Khánh Ward, Ho Chi Minh City, Vietnam
VOYAGE is located at 51 Lê Văn Miến Street, An Khánh Ward, Ho Chi Minh City, Vietnam

At the centre of this understated universe is chef-owner Jonathan Koh, whose cooking reflects a deeply personal dialogue between classical French discipline and the emotional nuance of Asian flavours. His tasting menus unfold with quiet intention, guiding diners through shifting textures, subtle contrasts, and moments of gentle revelation.

For Jonathan, modern haute cuisine begins not with technique or luxury, but with feeling. Each menu is shaped by the impression he hopes guests will carry with them long after the evening ends. From this emotional starting point, the journey takes form — guided by seasonality, intuition, and a measured sense of pacing.

The dining room mirrors this philosophy. Light is softened, sound absorbed, movement purposeful yet unhurried. There is a sense that time has been recalibrated. Service arrives with calm precision, allowing guests to settle into a slower cadence where attention sharpens and details quietly emerge.

On the plate, classical French training provides structure without insistence. Sauces are reduced with discipline, pastry work reveals patience, and proteins are handled with technical sensitivity. Yet these foundations remain discreet – an invisible framework that allows each ingredient to express itself with clarity.

The experience opens with a series of understated bites, subtle at first, yet quietly unfolding. A tart of otoro, shima aji and ikura plays on contrast – richness, brightness, and a gentle burst, contained within a shell that shifts in texture. A warm seaweed brioche carries bafun uni, layered with softly melted lardo and lifted by a restrained touch of yuzu kosho. Alongside, a slender croustillant gives way to a delicate salmon mousse – light, balanced, and quietly expressive. Together, these opening gestures set the tone: where texture leads, and restraint defines.

Equally central is Jonathan’s commitment to Vietnamese terroir. Ingredients drawn from the highlands of Đà Lạt – heirloom tomatoes with natural sweetness, herbs carrying a vivid aromatic lift – bring brightness and immediacy to the progression. In a defining course, tomatoes are explored through layered preparations, moving from raw clarity to concentrated depth. The result is both elemental and refined – a quiet tribute to the land that surrounds the restaurant.

Texture becomes a language through which emotion is expressed. Crisp elements dissolve into warmth, aerated forms yield to savoury depth, and fragile pastry layers fracture with precision. A reinterpretation of gougères arrives feather-light yet deeply flavoured, while a mille-feuille reveals meticulous lamination and restrained sweetness. These dishes evoke memory and tradition, yet remain unmistakably contemporary.

The pacing of the menu carries a cinematic sensibility. Early courses introduce brightness and curiosity, gradually giving way to deeper, more contemplative tones. The progression unfolds with continuity, encouraging guests to remain present within the narrative rather than experience it in fragments.

The development of each dish is intentionally unhurried. Months may be spent refining a single idea, tasting repeatedly until balance reveals itself. For Jonathan, completeness lies not in perfection, but in honesty – the moment a dish expresses precisely what it intends, without excess or distraction.

Opening VOYAGE in Vietnam has, in turn, shaped both the chef and his cuisine. The unpredictability of seasonal produce demands adaptability, while the openness of local diners has nurtured a quiet sense of creative freedom.

About Chef-Owner Jonathan Koh

Born into a family spanning four generations in the culinary world, Jonathan’s path into the kitchen was less a decision than a natural calling – one shaped in the warmth of his grandmother’s hawker stall. These early experiences instilled a deep respect for ingredients, long before technique entered the conversation.

This foundation was later refined through his time in Michelin-starred kitchens, including Le Jardin des Sens, La Villa Augusta in France, Voyage and Raffles Grill in Singapore, where discipline, precision, and restraint became second nature.

 

About VOYAGE

With a perspective shaped by years of global culinary experience, VOYAGE reflects a quieter vision of fine dining – one defined not by display, but by intention, clarity, and emotional resonance.

From the pristine coasts of Japan to the pastoral landscapes of Europe, each element is sourced with care, refined with precision, and presented with quiet integrity.

 

Contact information for reservations and inquiries:

Website: https://voyage-saigon.com/reservation

Fanpage: https://www.facebook.com/voyageinsaigon

All detailed information regarding reservation terms and conditions is fully updated on the website, helping guests better prepare for their culinary journey at VOYAGE.

 

Furrbby Defines 2026 Feline Hygiene Standards: Nationwide Launch of Premium Stainless Steel Litter Box Collection

Featuring an advanced sifting system, specialized XL/XXL sizing for large breeds, and a designer “Hidden Plant” collection—Furrbby offers a durable, antibacterial, and eco-friendly alternative to traditional plastic.

NEW YORK, March 27, 2026 /PRNewswire/ — Recent industry insights indicate a surge in demand for non-plastic pet essentials, with the stainless steel cat litter box category seeing a significant uptick, now surpassing 33,100 monthly searches. This trend reflects a growing movement among hygiene-conscious owners toward “buy-it-for-life” products that prioritize both feline long-term health and environmental sustainability.

Driven by this shift toward medical-grade hygiene, Furrbby today announces the nationwide launch of its flagship Stainless Steel Cat Litter Box 2026 collection. This new collection not only resolves chronic hygiene failures of traditional products through material innovation but also aligns with eco-friendly values—reducing plastic waste by eliminating the need for frequent replacements.

Beyond Plastic: Resolving the “Hidden Struggles” of Pet Ownership

Traditional plastic boxes often create a cycle of frustration. Plastic is prone to microscopic scratches that breed bacteria and trap persistent odors, which can contribute to feline health issues like chin acne (folliculitis).

In contrast, Furrbby utilizes medical-grade stainless steel that is naturally non-porous and rust-resistant. This heavy-duty construction ensures the box will not crack or absorb smells, effectively eliminating the labor-intensive scrubbing required by plastic models. For owners of large cats and multi-cat households, these material advantages provide a permanent, hygienic solution to household odors.

Efficiency for Modern Living: The Sifting Innovation

Furrbby is revolutionizing pet hygiene with its proprietary Stainless Steel Sifting System, engineered to eliminate the hassle of manual scooping. Crafted for durability and superior hygiene, these systems offer a tailored cleaning experience for every type of cat owner:

Sifting system for Clumping Litters (Clay or Tofu): Our high-efficiency sifting pan achieves a full-bed refresh in just three seconds. By flawlessly isolating waste from clean litter, it ensures a pristine litter bed after every use, significantly extending the life of your litter and saving you money.

Sifting system for Non-Clumping Litters (Pine Pellets): Say goodbye to tedious manual sifting. Furrbby’s advanced wet-dry separation system keeps sawdust away from fresh litter. This design effectively prevents bacterial growth and moisture buildup, making deep cleans effortless and keeping your home odor-free.

Thoughtfully Designed for Every Cat and Every Space

Recognizing that every feline’s needs are unique, the Furrbby 2026 collection offers versatile configurations:

High-Sided & XL/XXL Models: Specifically engineered to prevent “high-spraying” leaks and contain litter scatter. These massive basins provide ample turning space for large breeds like Maine Coons up to 30 lbs.

Hidden Round Potted Plant Model: This innovative design disguises the litter box as high-end home decor, perfectly blending superior hygiene with modern apartment aesthetics.

Space-Saving Geometry: Round and Triangular (Corner) designs allow owners to maximize usable floor space in smaller urban apartments without sacrificing the cat’s comfort.

Inclusive Access: Low-entry designs with integrated steps ensure senior cats or those with mobility challenges can enter and exit with ease.

A Sustainable Investment in Feline Health

Every Furrbby product features a sleek, minimalist design with rounded safety edges to protect both pets and floors. These durable, long-lasting boxes represent a sustainable investment, ending the cycle of disposable plastic use while promoting a cleaner, more beautiful lifestyle for modern pet families.

About Furrbby

Furrbby aims to set a new standard by leading the next generation of pet care essentials. We are on a mission to redefine the industry through purposeful design and material innovation. By prioritizing premium stainless steel—a material naturally antibacterial, odor-resistant, and virtually indestructible—Furrbby creates “buy-it-for-life” solutions that prioritize feline health and environmental sustainability.

For more information and to explore the full 2026 collection, please visit https://furrbby.com.

Contact Us:

Email: marketing@furrbby.com or support@furrbby.com

Follow Our Social Media: 

INSTAGRAM

FACEBOOK

PINTEREST

YOUTUBE

Akeso Reports Full-Year 2025 Financial Results

HONG KONG, March 27, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced its 2025 annual results, highlighting a year of comprehensive, strategic leaps across all facets of its business.

Commercial Operations Enter a New Phase of Growth

In 2025, Akeso achieved record commercial sales revenue of RMB3,033.1 million, a 51.48% year-on-year increase. All approved products and indications are now included in China’s National Reimbursement Drug List (NRDL). The strong commercial growth in 2025 was fueled by strong clinical validation and widespread adoption by both healthcare professionals and patients.

By the end of 2025, several high-impact indications were added to the latest NRDL, including:

  • Ivonescimab: 1L PD-L1(+) NSCLC
  • Cadonilimab: 1L gastric cancer and 1L cervical cancer
  • Other products: Multiple indications for penpulimab, ebdarokimab and ebronucimab

With stable pricing for core first-line (1L) indications and improved hospital access, Akeso’s commercial platform is positioned for a transformative 2026.

Advanced Clinical Development of IO 2.0 Bispecifics

Ivonescimab (PD-1/VEGF):

As the world’s first and only approved PD-1/VEGF bispecific antibody, ivonescimab solidified its global leadership in 2025 by iterating upon existing Standards of Care (SOC) to reshape the oncology landscape. Ivonescimab has benefited approximately 70,000 patients to date.

Ivonescimab’s IO 2.0 value is anchored by a series of landmark Phase III victories: in the HARMONi-2 study, ivonescimab achieved a head-to-head win against pembrolizumab in 1L PD-L1(+) NSCLC, establishing a new “chemo-free” standard. Additionally, the HARMONi-A study marked it as the first immunotherapy to reach dual PFS and OS positivity in EGFR-TKI resistant NSCLC, while HARMONi-6 demonstrated its superiority over tislelizumab (anti-PD-1 monoclonal antibody) in combination with chemotherapy in 1L squamous NSCLC, successfully overcoming traditional anti-VEGF contraindications for squamous histology.

Currently, the U.S. FDA has accepted the BLA from our partner Summit Therapeutics for ivonescimab plus chemotherapy in nsq-NSCLC following third-generation EGFR-TKI failure. As the only commercialized PD-1/VEGF bispecific globally, ivonescimab has secured two approved lung cancer indications in China (both NRDL-listed) with another sNDA under review for the first-line treatment of advanced squamous NSCLC. The Company’s expansive global development program now encompasses 15 Phase III trials, including 5 global studies and 7 head-to-head studies against PD-1/L1 therapies, targeting critical 1L indications, IO-resistant, and “cold” tumors.

Cadonilimab (PD-1/CTLA-4):

Cadonilimab (PD-1/CTLA-4) is the world’s first and only approved bispecific antibody of its class. With approximately 120,000 patients treated to date, it has demonstrated “all-comer” clinical benefits across multiple tumor types. Its exceptional efficacy in treating challenging cases, such as IO-resistant and “cold” tumors, has solidified its status as a cornerstone therapy in the IO 2.0 era.

Akeso is advancing 12 registrational or Phase III clinical trials for cadonilimab globally, covering more than 10 major cancer types and spanning the full treatment lifecycle and clinical scenarios. Furthermore, the Company is spearheading two international registrational studies: a head-to-head Phase III trial against nivolumab in first line gastric cancer, and a registrational trial for IO-resistant hepatocellular carcinoma (HCC). These high-efficiency global studies aim to address significant unmet medical needs, further unlocking cadonilimab’s global therapeutic value.

Oncology Therapy Matrix Continues to Expand

Akeso is pioneering the IO 2.0 + ADC 2.0 strategy, expanding its portfolio from bispecifics into trispecifics and TCE platforms. the Company is fast-tracking the global development of its next-gen ADCs, such as the bispecific Trop2/Nectin4 AK146D1, and the HER3 AK138D1. By combining these with its core IO assets (cadonilimab and ivonescimab), Akeso aims to address the narrow therapeutic windows associated with traditional ADCs. With AK150 (trispecific) now in the clinic and more trispecific/multispecific antibodies and TCE bispecific/multispecific antibodies approaching clinical entry, Akeso is rapidly building a formidable, next-generation oncology matrix.

Paradigm Shift in Bispecific Excellence: Continuous Expansion of the Oncology Portfolio

Akeso is methodically extending its IO 2.0 leadership into the emerging ADC 2.0 landscape, thereby operationalizing its integrated “IO 2.0 + ADC 2.0” platform thesis while systematically advancing bispecific antibody expertise into higher order trispecific/multispecific antibodies and TCE platforms. In the area of IO, Akeso remains the sole global player with two approved immuno-oncology bispecifics, a distinction that confers both first-mover clinical validation and a proprietary data moat in dual-check point/dual-pathway blockade. On the ADC front, the Company’s next-generation candidates, notably bispecific ADC AK146D1 and novel ADC AK138D1, are purpose-engineered to overcome the narrow therapeutic window that chronically plagues current ADCs, advancing the field into ADC 2.0.

Phase II trials combining these proprietary ADCs with cadonilimab and ivonescimab are now underway, with global expansion planned. Both IO bispecifics are also being explored broadly with external high-potential ADCs. Meanwhile, the Company’s first trispecific antibody, AK150, is in clinical development, with more trispecific/multispecific and TCE assets approaching the clinic.

Immune and CNS Diseases Enter the Dual-Target Era

Beyond building global competitiveness in oncology, Akeso has created a powerful new growth engine in immune-related diseases. Leveraging its bispecific and multispecific antibody platforms, the Company is advancing a pipeline of novel candidates in autoimmune, respiratory, allergy, and CNS indications, including AK139, AK152 (siRNA), KF111 (siRNA), and KF115 (siRNA), alongside commercial-stage products like ebdarokimab, gumokimab and manfidokimab. This layered portfolio is rapidly strengthening Akeso’s global presence beyond oncology.

AI-Powered R&D and Cutting-Edge Platforms

Building atop its globally competitive command in monoclonal and bispecific antibody development, Akeso has executed a deliberate expansion into frontier therapeutic modalities by embedding AI end-to-end across the entire R&D and manufacturing continuum – from discovery and cell-line/process development through to smart manufacturing. The outcome is a tightly orchestrated portfolio of differentiated platforms: the Tetrabody antibody technology platform, the AI-powered drug R&D platform, the Dual-Shield ADC technology platform, the Dual-Lock T-cell engager (TCE) technology platform, the Tissue-Smart siRNA/mRNA technology platform, and the cell therapy technology platform. These assets collectively solidifies Akeso’s global innovation edge, unlocking 0-to-N breakthroughs across multiple high-barrier domains where conventional therapeutic modalities have historically stalled.

Akeso continues to iterate and scale its AI-powered, integrated drug discovery platform, which now provides comprehensive coverage across the entire R&D lifecycle for both antibody and nucleic acid therapeutics, while extending into additional frontier modalities. At its core lies a proprietary AI technology matrix that fuses high-precision structure prediction, immunogenicity prediction, fully automated humanization, and one-step sequence optimization. This closed-loop, data-rich architecture enables end-to-end precise engineering from sequence design to clinical development, significantly accelerating the efficient and high throughput development of innovative therapies.

Dr. Michelle Xia, Founder, Chairwoman, President, and CEO of Akeso, commented:

“2025 marked a definitive strategic leap for Akeso across commercialization, global clinical expansion, and our broadening multi-platform innovation ecosystem. We achieved over 50% sales revenue growth. This success provides a powerful springboard for continued commercial and clinical execution in 2026.

We are now pioneering a shift in therapeutic paradigms. Leveraging our leadership in IO bispecifics, we are expanding into ‘IO 2.0 + ADC 2.0,’ including bispecific ADCs, trispecifics, and TCE platforms. Beyond oncology, we are bringing the immense therapeutic benefit of bispecific antibodies to immunology, respiratory, and CNS diseases, all powered by our integrated AI discovery engine.

Our vision to bring transformative and life saving medicine to every patient on Earth is coming to fruition. With over ten products in international trials, including studies that includes ivonescimab and cadonilimab, we are advancing our mission to deliver world-class medicines to patients worldwide. By integrating global talent, capital, and R&D resources, and integrating AI into our research and development efforts, we are building a robust institutional framework to sustain Akeso’s long-term leadership in innovation in the global biopharmaceutical industry.”

About Akeso

Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has established a robust R&D innovation ecosystem centered on its Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform, Tissue-Smart siRNA/mRNA technology platform, and cell therapy technology platforms. Supported by a global-standard GMP manufacturing infrastructure and a highly efficient, integrated commercialization model, the company has evolved into a globally competitive biopharmaceutical focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 27 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

Forward-Looking Statements

This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

  

Creator Flow reports over 200% growth in 2025 as UGC demand accelerates across Australia

SYDNEY, March 27, 2026 /PRNewswire/ — Creator Flow, one of Australia’s fastest-growing user-generated content (UGC) platforms, has reported more than 200% year-on-year revenue growth in 2025, alongside a rapid expansion of its creator community.

Creator Flow team with leading UGC creators from its community
Creator Flow team with leading UGC creators from its community

The platform connects creators with more than 2,400 brands and agencies across Australia, reflecting a growing demand for scalable, performance-driven content – as digital advertising continues to prioritise speed, authenticity and adaptability.

Prash Balakrishnan, Chief Commercial Officer at Roar Global, said the platform’s performance signals a broader shift in how brands approach content. “AI makes content easier to produce, but human-created content still continues to drive better outcomes on performance – driven by authenticity and trust. CreatorFlow enables brands to scale this effectively.”

As brands move away from informal influencer sourcing, structured UGC models like Creator Flow are gaining traction. Built by advertising professionals, Creator Flow simplifies the campaign lifecycle – from briefing and creator matching through to delivery and payment – enabling fixed-cost commissioning, faster turnaround and scalable execution.

Creators typically deliver content within 72 hours of receiving a product and brief, allowing brands and agencies to move quickly from concept to deployment.

In 2025, Creator Flow was shortlisted for the AiMCO Awards under Best Influencer Marketing Technology/Service, marking its first major industry recognition. The platform also introduced new capabilities, including Concierge services for complex campaigns and Top-Rated Creators to help brands identify proven performers.

Ama Silva, Director Marketing and Operations at Creator Flow, said the platform’s evolution reflects growing expectations from both brands and creators. “Agencies want speed, precision and control, while creators want transparency and structure. Our role is to remove ambiguity and make collaboration seamless, with a clear focus on reducing friction.”.

Looking ahead, Creator Flow plans to expand its platform with additional services, alongside AI-powered enhancements to improve creator matching and campaign efficiency. The company will also launch Creator Flow Academy to support creators in building sustainable careers and improving content performance.

With continued growth across brand and agency partnerships, Creator Flow is positioning itself as a key infrastructure layer within Australia’s evolving UGC landscape.

About Creator Flow

Creator Flow is Australia’s leading self-servicing UGC marketplace, connecting brands and agencies with a fast-growing community of creators through a structured, end-to-end platform.

Creator Flow is a portfolio company of Roar Global, a mar-tech venture builder that builds, acquires and scales companies across platform ecosystems and AI.

Hikvision to unveil multidimensional AIoT ecosystem at Hannover Messe 2026, redefining industrial safety and smart manufacturing

HANGZHOU, China, March 27, 2026 /PRNewswire/ — Hikvision, a global leader in AIoT solutions, is set to participate in Hannover Messe 2026, the world’s premier industrial trade fair, taking place from April 20-24 at the Hanover Exhibition Center, Germany. Underscoring its commitment “Shaping Industrial Digitalization with AIoT,” Hikvision will exhibit at Hall 27-G84, demonstrating how AI-powered perception and intelligent analytics are transforming industrial operations across manufacturing, energy, and other critical sectors.

Hikvision to unveil multidimensional AIoT ecosystem at Hannover Messe 2026
Hikvision to unveil multidimensional AIoT ecosystem at Hannover Messe 2026

“Industrial digitalization powered by AIoT will fundamentally transform how manufacturers operate and grow,” said Derek Yang, Vice President of Hikvision International Business Center. “We welcome industry leaders and decision-makers to visit our booth, where our team will showcase solutions that don’t just monitor industrial operations—they predict, prevent, and optimize in real-time.”

Hikvision will feature a robust suit of AIoT solutions addressing four critical business imperatives for modern industry.

1. Prevent workplace incidents before they happen

  • PPE compliance monitoring: AI-powered visual detection ensures workers adhere to personal protective equipment requirements in designated zones, eliminating safety violations and fostering a strong culture of compliance.
  • Gas leak detection: Advanced laser sensing technologies identify hazardous gas leaks at the earliest stage, preventing environmental contamination and protecting worker safety.

2. Eliminate unplanned downtime with predictive intelligence

  • Temperature anomaly detection: High-precision thermal imaging identifies abnormal heat patterns in machinery, allowing for intervention before costly production interruptions.
  • Discharge detection: Acoustic imaging technology pinpoints partial discharge and abnormal sounds through precise source localization, enabling 24/7 online monitoring that extends equipment lifespan and reduces maintenance costs.

3. Maximize productivity with intelligent visibility

  • Production line monitoring: High-frame-rate cameras deliver full-process visual monitoring and automated retrospective analysis, significantly improving troubleshooting efficiency and ensuring production line stability.
  • Smart meter reading: Macro cameras capture sharp, detailed meter images, enabling remote inspection to reduce operational costs and human error.

4. Achieve uncompromised quality control

  • Automated defect detection: Enhanced by large-scale AI models, Hikvision’s X-ray inspection systems deliver superior detail enhancement and clearer defect visibility to safeguard product integrity and rigorous quality standards.
  • Silo volume measurement: Non-contact 3D millimeter-laser radar monitors material height and volume in storage silos accurately, optimizing inventory management and supply chain efficiency.

Visit Hikvision at Hannover Messe 2026

Date: April 20-24, 2026
Location: Messegelände, D-30521 Hannover, Germany
Booth: Hall 27-G84

Tech-Driven Restoration: Saving the World’s Critically Endangered White-headed Langur

  • Through decades of careful conservation efforts, the white-headed langur population has increased from just over 300 in the 1980s to more than 1,400 across 130 groups today.
  • An AI-powered system covers more than 20 monitoring stations in the Guangxi Chongzuo White-headed Langur National Nature Reserve. It has logged 37,200 detections of langur activity, which provide critical data for research and conservation.
  • To date, 77.6 hectares of habitat has been restored, 2 drinking water sources and 18 water drinking points for the langurs have been built, and 2 ecological corridors have been constructed.

CHONGZUO, CHINA – Media OutReach Newswire – 27 March 2026 – In the rugged karst mountains of Guangxi in Southern China, a primate species once on the brink of extinction – the white-headed langur – is steadily recovering in population thanks to a range of measures that bring together technology, law enforcement, and ecological restoration.

Photo for PR2.jpg

Found exclusively in Chongzuo, Guangxi, the white-headed langur is listed as Critically Endangered by the IUCN Red List of Threatened Species and the Red List of China’s Vertebrates. New monitoring data reveals that the “stone mountain elf”, which is even rarer than the giant panda, is no longer on the brink of extinction. Through the combined efforts of the local government, the nature reserve, academia, and the tech sector, the survival crisis triggered by habitat fragmentation has been significantly reversed for this species.

Photo 2.jpg

To address the challenges posed by the rugged karst terrain and the difficulties of traditional patrol and monitoring, the nature reserve teamed up with Huawei and the China-ASEAN Artificial Intelligence Application Cooperation Center to develop an intelligent monitoring platform powered by AI computing. Thanks to the video-based animal monitoring devices deployed along the cliffs, the system can collect real-time data on the langurs’ distribution, surroundings, and patterns of activity. Using AI-driven automated labeling and data analytics, the reserve has developed a complete dashboard for visualized management. This has significantly enhanced the efficiency of data retrieval and analysis. To date, the system has recorded over 37,200 instances of langur activity.

In addition to technical support, innovation in ecological protection and restoration mechanisms is also critical. The Chongzuo White-Headed Langur Habitat Protection Regulations, the first regulation of its kind in China, forms the legal framework for the reserve’s protection efforts. Under this framework, a range of measures has been implemented. To date, 77.6 hectares of habitat has been restored, 2 drinking water sources and 18 water drinking points for the langurs have been built, and 2 ecological corridors have been constructed. The white-headed langur population has increased to more than 1,400 across 130 groups. As the langur is an umbrella species of the local karst ecosystem, the growth of its population is critical to the region’s biodiversity. Wild duck lettuce, a level-II protected species in China, was recently found in the reserve for the first time, a sign of recovery in the fragile local ecosystem.

Nong Dengpan, Director of the Guangxi Chongzuo White-headed Langur National Nature Reserve Management Center, said: “The growth of the white-headed langur population can be attributed to a combination of technology, legislation, and ecological restoration efforts. Digital technology enables more precise observation of these limestone langurs and more informed management of their living environment. This integrated conservation model can serve as a reference for the protection and population recovery of other endangered primate species, such as the eastern black crested gibbon in Southeast Asia.”

Tian Yongsheng, Deputy General Manager of Huawei Guangxi, noted: “Huawei is committed to conserving nature with technology. We work with global partners to support ecosystem conservation using digital technologies like 5G, cloud, and AI. The success of the white-headed langur project demonstrates AI’s immense value in processing complex geographical data and massive volumes of species data. We will continue using innovative technologies to protect biodiversity and enable the harmonious coexistence of humanity and nature.”

By the end of 2025, our digital inclusion projects for environmental protection had been implemented in 65 protected areas around the world. These projects have significantly improved the efficiency of biodiversity conservation and the sustainable use and management of natural resources.

Hashtag: #Huawei

The issuer is solely responsible for the content of this announcement.